CSL
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
read more
Details
The company has raised a total of $111M. Learn more about Hidden Gem and Efficiency Scores.
Industries
Products
Technologies
Features
The following 0 companies are top matches based on Iterate's Proprietary algorithms.
CSL Highlights
Funding
$111M
±0
YoY
Headcount
20.8K
+18.7K
YoY
Patents
1.2K
±0
YoY
News
96
1 Funding Rounds
Post-IPO Equity
$111M
2004-02-06
Investors
Unknown
Add Funding Round
No results found
Try your search again with different filters.